肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
临床试验招募
登录/注册
VIP特权
广告
广告加载中...

文章:

儿童及青少年癌症患者神经病理性疼痛的管理挑战

The Challenge of Managing Neuropathic Pain in Children and Adolescents with Cancer

原文发布日期:29 January 2025

DOI: 10.3390/cancers17030460

类型: Article

开放获取: 是

 

英文摘要:

Neuropathic pain (NP) is a common complication associated with some types of childhood cancer, mainly due to nerve compression, chronic post-surgical pain, chemotherapy, and radiotherapy. NP is usually less responsive to traditional analgesics, and there is generally a lack of evidence on its management in cancer patients, leading to recommendations often based on clinical trials conducted on other forms of non-malignant NP. In pediatric oncology, managing NP is still very challenging for physicians. Different factors contribute to increasing the risk of undertreatment: (a) children may be unable to describe the quality of pain; therefore, the risk for NP to be underestimated or remain unrecognized; (b) specific tools to diagnose NP have not been validated in children; (c) there is a lack of randomized clinical trials involving children, with most evidence being based on case series and case reports; (d) most drugs used for adult patients are not approved for childhood cancers, and drug regulation varies among different countries; (e) recommendations for pediatric pain treatment are still not available. In this paper, a multidisciplinary team will review the current literature regarding children with cancer-related NP to define the best possible diagnostic strategies (e.g., clinical and instrumental tests) and propose a therapeutic care pathway, including both non-pharmacological and pharmacological approaches, which could help pediatricians, oncologists, neurologists, and pain therapists in designing the most effective multidisciplinary approach.

 

摘要翻译: 

神经病理性疼痛是某些类型儿童癌症的常见并发症,主要源于神经压迫、慢性术后疼痛、化疗及放疗。传统镇痛药物对该类疼痛通常疗效有限,且目前普遍缺乏针对癌症患者神经病理性疼痛管理的循证依据,导致临床建议多基于非恶性神经病理性疼痛的临床试验数据。在儿科肿瘤学领域,神经病理性疼痛的管理对临床医生仍具重大挑战。多种因素增加了治疗不足的风险:(a) 儿童可能无法准确描述疼痛性质,导致神经病理性疼痛易被低估或漏诊;(b) 特异性神经病理性疼痛诊断工具尚未在儿童群体中得到验证;(c) 缺乏涉及儿童的随机临床试验,现有证据多基于病例系列和病例报告;(d) 多数成人用药未获批用于儿童癌症治疗,且各国药物监管政策存在差异;(e) 儿童疼痛治疗指南体系尚不完善。本文将通过多学科团队协作,系统回顾当前儿童癌症相关神经病理性疼痛的文献,旨在确立最优诊断策略(包括临床及器械检查),并提出涵盖非药物与药物干预的治疗路径,为儿科医师、肿瘤学家、神经科医师及疼痛治疗师构建高效的多学科诊疗方案提供参考。

 

原文链接:

The Challenge of Managing Neuropathic Pain in Children and Adolescents with Cancer

广告
广告加载中...